Diabetes and Psoriasis

Patients with psoriasis will be evaluated. The investigators will collect personal history, concomitant diseases and in particular the presence of type 2 diabetes mellitus, impaired fasting glucose and impaired glucose tollerance. The aim of the study will be to evaluate if there is a correlation among inflammation, insulin-resistance and psoriasis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diabetes Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Hyperinsulinism Inflammation Insulin Resistance Metabolic Diseases Nutritional and Metabolic Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Psoriasis Skin Diseases Skin Diseases, Papulosquamous Skin and Connective Tissue Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

IRCCS Policlinico San Matteo Foundation

Pavia, 27100, Italy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients with psoriasis

Exclusion criteria

Treatment and study plan

PASI and HOMA index

Other

Primary outcomes

Evaluation of correlation between diabetes and psoriasis

Time frame: 3 years

Sponsors and collaborators

Lead sponsor

University of Pavia

Other

Collaborators

Fondazione IRCCS Policlinico San Matteo di Pavia

Registry information

Official study title

Diabetes and Psoriasis: Study on Prevalence, Role of Inflammation and Insulin-resistance

Important dates

Study start: 2015
Primary completion: 2018
Study completion: 2018
First posted: Feb 19, 2015
Registry last updated: May 24, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed